DIRECT BILIRUBIN (DBIL)— 510(k) K981222

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K981222 for DIRECT BILIRUBIN (DBIL), Substantially Equivalent on 1998-04-24. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code CIG
Advisory panel: Clinical Chemistry
Date received: 1998-04-03
Decision date: 1998-04-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.